Abstract:Abstract Deregulation of ribosomal subunit levels and accessibility are hallmarks of cancer. Eukaryotic translation initiation factor 6 (eIF6) is a key regulator of ribosomal subunit association that is over expressed in many cancers including lung, colon, ovarian and breast cancers, and deregulation of eIF6 is correlated with a poor cancer prognosis. Association of eIF6 with 60S is critical for 60S assembly. However, eIF6 must be released from 60S prior to translation to permit inter subunit interactions between 60S and 40S and to facilitate the formation of translationally proficient 80S monosome. Release of eIF6 is deregulated in the ribosomopathy- Shwachman Diamond Syndrome that is predisposed to leukemias. Also, loss of eIF6 markedly delays tumorigenesis without affecting normal growth, which presents eIF6 as a viable therapeutic target. A potential therapeutic strategy is to target the eIF6 and 60S ribosomal interaction interface. Through biophysical analyses we had identified residues that are critical for the interaction between eIF6 and 60S ribosomal subunit. We show that targeting these key residues in the eIF6-60S interaction interface markedly delays colonic cancer growth and inhibits protein synthesis. Furthermore, we show that the levels of other eIFs and the release factors: SBDS, and EFL1-GTPase are unaltered in the mutant cells suggesting that the translational inhibition is primarily attributed to the deregulation of eIF6. Interestingly, targeting eIF6 leads to an upregulation of p53 independent of the DNA damage response, suggesting that ribosomal stress contributes to the stabilization of p53. Previously, it was shown that translation of Cdc42 was upregulated by eIF6 to promote invasiveness. However, Cdc42 levels were unaltered in the mutant cells. Future studies will determine the mRNA substrates that are translationally deregulated in the mutants. We will also determine the effect of disrupting eIF6 function in inhibiting tumor growth and progression in vivo. Category: MCB, Subcategory: MCB07-Gene regulation sub classification: Translational Control Citation Format: Kavya Meena Harish, Poonam Roshan, Aparna Biswas, Stella Anagnos, Riley Luebbers, Sofia Origanti. Targeting eIF6 to modulate ribosomal subunit association dynamics in cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 7078.

The Tumor Suppressive Role of eIF3f and Its Function in Translation Inhibition and rRNA Degradation

Eukaryotic Translation Initiation Factor 3 and Tumor

eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

Translational Regulator Eif2α in Tumor

Research progress on eIF3 a and cancer

Translational Regulation by eIFs and RNA Modifications in Cancer

Eif3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

Downregulation Of Eukaryotic Translation Initiation Factor 3b Inhibited Proliferation And Metastasis Of Gastric Cancer

Eukaryotic translation initiation factors and cancer.

Eukaryotic Translation Initiation Factors and Tumor

eIF3a Regulates Colorectal Cancer Metastasis via Translational Activation of RhoA and Cdc42

Overexpression of Eif3e is Correlated with Colon Tumor Development and Poor Prognosis.

Perturbations in eIF3 subunit stoichiometry alter expression of ribosomal proteins and key components of the MAPK signaling pathways.

The Regulation of Protein Translation and Its Implications for Cancer

eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation

Knockdown of EIF3H Inhibits the Development and Progression of Pancreatic Cancer by Regulating Cell Proliferation and Apoptosis in Vitro

A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation

The Biological Roles Of Translation Initiation Factor 3b

Abstract 7078: Targeting eIF6 to modulate ribosomal subunit association dynamics in cancers

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis